Effects physical activity on creatinine, and metabolic syndrome in females with transplanted kidney
Subject Areas : Journal of Physical Activity and Hormones
Eskandar Rahimi
1
(Associate professor in exercise physiology, Department of exercise physiology, Shiraz branch, Islamic Azad University, Shiraz, Iran)
Khatoun Tahmouresi
2
(MS in exercise physiology, Department of exercise physiology, Shiraz branch, Islamic Azad University, Shiraz, Iran)
Seyed Ali Hosseini
3
(Associate professor in exercise physiology, Department of exercise physiology, Marvdasht branch, Islamic Azad University, Marvdasht, Iran)
Saman Eskandary
4
(MS in exercise physiology, Department of exercise physiology, Marvdasht branch, Islamic Azad University, Marvdasht, Iran)
Keywords:
Abstract :
1. Howden EJ, Fassett RG, Isbel NM, Coombes JS. Exercise training in chronic kidney disease patients. Sport Med 2012; 42: 473-488.
2. Orlando R, Mussap M, Plebani M, Piccoli P, De Martin S, Floreani M et al. Diagnostic value of plasma Cystatin C as a glomerular filtration marker in decompensated liver cirrhosis. Clin Chem 2002; 48: 850-858.
3. Samyn M, Cheeseman P, Bevis L, Taylor R, Samaroo B, Buxton-Thomas M et al. Cystatin C, an easy and reliable marker for assessment of renal dysfunction in children with liver disease and after liver transplantation. Liver Transpl 2005; 11: 344-9.
4. Heymsfield SB, Arteaga C, Maccanus C, Smith J, Moffitt S. Measurement of muscle mass in humans: validity of the 24-hour urine creatinine method. Am J Clinic Nutrit 1983; 37:478-494.
5. Stevens LA, Coresh J, Feldman HI. Evaluation of the modification of diet in renal disease study equation in a large diverse population. J Am Soc Nephrol 2007; 18: 2749 -2757.
6. Stevens LA, Levey AS. Measured GFR as a confirmatory test for estimated GFR. J Am Soc Nephrol 2009; 20:2305-2313.
7. Johansen KL. Exercise in the end-stage renal disease population. J Am Soc Nephrol 2007; 18: 1845- 1854.
8. Johansen KL, Painter P. Exercise in individuals with CKD. Am J Kidney Dis 2011; 59: 126-134.
9. Haskell WL, Lee IM, Pate RR. Physical activity and public health: updated recommendation from the American College of Sports Medicine and the American Heart Association. Med Sci Sports Exerc 2007; 39: 1423-1434.
10. Winnick JJ, Sherman WM, Habash DL, Stout MB, Failla ML. Short-term aerobic exercise training in obese humans with type 2 diabetes mellitus improves whole-body insulin sensitivity through gains in peripheral, not hepatic insulin sensitivity. J Clin Endocrinol Metab 2008; 93: 771-778.
11. Cheung HW, Chan YL, Liu YH, Chan HS, Wong WL, Chak KS, et al. Prevalence of metabolic syndrome in Chinese renal transplant recipients. Hong Kong Med J 2008; 14: 379-384.
12. Donald EH. Metabolic syndrome in kidney transplantation: Management of risk factors. Clin J Am Soc Nephrol 2011; 6: 1781-1785.
13. Serin E, Coknaz H, Semsek O. Cystatin-C levels in serum after sub-maximal exercise. Aibü Izzet Baysal Tip Dergisi Cilt 2009; 4: 2-4.
14. Baxmann AC, Ahmed MS, Cristina Marques N, Menon VB, Pereira AB. Influence of muscle mass and physical activity on serum and urinary creatinine and serum cystatin C. Clin J Am Soc Nephrol 2008; 3: 348-354.
15. Vigil L, Lopez M, Condes E, Varela M, Lorence D, Garcia-Carretero R et al. Cystatin C is associated with the metabolic syndrome and other cardiovascular risk factors in a hypertensive population. J Am Soc Hypertens 2009; 3: 201-209.
16. Churilla JR, Zoeller Jr RF. Physical activity and the metabolic syndrome: A review of the evidence. Am J Lifestyle Med 2008; 2: 118-125.
17. Eskandary S, Rahimi E. Effects of eight weeks of aerobic training, resistance training and concurrent training on the metabolic syndrome and HbA1c in men with type 2 diabetes. J Physic Act Horm 2017; 1: 51-64.
18. Bruce CR, kriketos AD. Disassociation of muscle triglyceride content and insulin sensitivity after exercise training in patients with type 2 diabetes. Diabetologia 2004; 47: 23-30.
19. Cleeman J I. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA 2001; 285: 2486-2497.
20. Rahimi E, Chahardah Cheric M. Prevalence of overweight and obesity and their relation to hypertension in adult male population of Fars province of Iran. Pak J Med Res 2012; 51: 97-100.
21. Bijeh N, Farahati S. The effect of six months of aerobic training on renal function markers in untrained middle-aged women. Intern J Sport Studies 2013; 3:218-224.
22. Rafati FM, Taghian F, Pakfetrat M, Daryanoosh F, Mohammadi H. The effect of aerobic training on the amount of GFR and excreted of creatinine in patients with chronic kidney. J Arm Univers 2012; 9:264-270.
23. Straznicky NE, Grima MT, Lambert EA, Eikelis N, Dawood T, Lambert GW, et al. Exercise augments weight loss induced improvement in renal function in obese metabolic syndrome individuals. J Hypertens 2011; 29 (3):553-64.
24. Pechter U, Ots M, Mesikepp S, Zilmer K, Kullissaar T, Vihalemm T, et al. Beneficial effects of water-based exercise in patients with chronic kidney disease. Intern J Rehabil Res 2003; 26:153-156.
25. Mohammadi V, Keshtkar-Aghababaee S. Prevalence of overweight and obesity in kidney transplant patients. Zahedan J Res Med Sci (ZJRMS) 2014; 16: 35.
26. Chen J, Muntner P, Hamm LL, Jones DW, Batuman V, Fonseca V, et al. The metabolic syndrome and chronic kidney disease in US adults. Ann Intern Med 2004; 140: 167-174.
27. Serin E, Coknaz H, Semsek O. Cystatin-C levels in serum after sub-maximal exercise. Aibü Izzet Baysal Tip Dergisi Cilt 2009; 4: 2-4.
28. Baxmann AC, Ahmed MS, Cristina Marques N, Menon V B, Pereira AB. Influence of muscle mass and physical activity on serum and urinary creatinine and serum Cystatin C. Clin J Am Soc Nephrol 2008; 3: 348-354.
29. Zoccali C. Overweight, obesity and metabolic alterations in chronic kidney disease. Prilozi 2009; 30: 17-31.
30. Chen J, Muntner P, Hamm LL, Jones DW, Batuman V, Fonseca V, et al. The metabolic syndrome and chronic kidney disease in US adults. Ann Intern Med 2004; 140: 167-174.
31. Lakka TA, Laaksonen DE. Physical activity in prevention and treatment of the metabolic syndrome. Appl Physiol Nutr Metab 2007; 32: 76-88.
32. Shenoy S, Ekta A, Sandhu J. Effects of progressive resistance training and aerobic exercise on type 2 diabetics in Indian population. Int J Diabete Metab 2009; 17: 27-30.
33. Bruce CR, kriketos AD. Disassociation of muscle triglyceride content and insulin sensitivity after exercise training in patients with type 2 diabetes. Diabetologia 2004; 47: 23-30.
34. Eriksson J, Taimela S, Eriksson K, Parviainen S, Peltonen J, Kujala U. Resistance training in the treatment of non-insulin-dependent diabetes mellitus patients with type 2 diabetes. Diabetes Care 2002; 25: 1729-36.
35. Vincent HK, Bourguignon C, Vincent KR. Resistance training lowers exercise-induced oxidative stress and homocysteine levels in overweight and obese older adults. Obesity 2006; 14: 1921-1930.
36 Sheen J, Sheu W. Metabolic syndrome and renal injury: Yi Cardiol Res Practice 2011; 10: 56-61.
37. Heng BH. The Singapore national health care group registry descriptive epidemiology of diabetes type2, Ann Acad Med Singapore.2010; 39: 348-352.
38. Misra A, Alappan NK, Vikram NK, Goel K, Gupta N, Mittal K, et al. Effect of supervised progressive resistance-exercise training protocol on insulin sensitivity, glycemia, lipids, and body composition in Asian Indians with type 2 diabetes. Diabetes Care 2008; 31: 1282-1287.
39. Holloszy JO, Schultz J, Kusnierkiewicz J, Hagberg JM, Ehsani AA. Effects of exercise on glucose tolerance and insulin resistance: brief review and some preliminary results. Acta Med Scand Suppl 1986; 711: 55-65.
40. Perseghin G, Price TB, Petersen KF, Roden M, Cline GW, et al. Increased glucose transport-phosphorylation and muscle glycogen synthesis after exercise training in insulin-resistance subjects. N Engl J Med 1996; 335: 1357-1362.
41. Mohbi H, Khazaei MH, Esfahani M. Effects of aerobic exercise on blood glucose control, cardiovascular and respiratory fitness and risk factors associated with cardiovascular disease –in patients with mild and severe non-insulin dependent diabetes. Olympic 2006; 4: 17-24 [Persian].
42. Sigal RJ, Kenny GP, Boulé NG, Wells GA, Prud'homme D, Fortier M, et al . Effects of aerobic training, resistance training, or both on glycemic control in type 2 diabetes: a randomized trial. Ann Intern Med 2007; 147: 357-69.
43. Gustat J, Srinivasan SR, Elkasabany A, Berenson GS. Relation of self-rated measures of physical activity to multiple risk factors of insulin resistance syndrome in young adults: the Bogalusa Heart Study. J Clin Epidemiol 2002; 55: 997-1006.
44. Lakka TA, Laaksonen DE, Lakka HM, Männikkö N, Niskanen LK, Rauramaa R, et al. Sedentary lifestyle, poor cardiorespiratory fitness, and the metabolic syndrome. Med Sci Sports Exerc2003; 35: 1279-1286.
45. Rennie K L, McCarthy N, Yazdgerdi S, Marmot M, Brunner E, Association of the metabolic syndrome with both vigorous and moderate physical activity. Intern J Epidemiol 2003; 32: 600-606.
46. McMurray RG, Andersen L B. The influence of exercise on metabolic syndrome in youth: a review. Am J Lifestyle Med 2010; 4: 176-186.
47. Pedersen BK, Febbraio MA, Mooney RA. Interleukin-6 does/does not have a beneficial role in insulin sensitivity and glucose homeostasis. J Appl Physiol 2007; 102: 814-819.
